Check-Cap (CHEK) Competitors $0.64 -0.01 (-1.24%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CHEK vs. DRCT, SLGL, BTCY, NXL, TNON, MHUA, XAIR, LYRA, DHAI, and OSRHShould you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), Biotricity (BTCY), Nexalin Technology (NXL), Tenon Medical (TNON), Meihua International Medical Technologies (MHUA), Beyond Air (XAIR), Lyra Therapeutics (LYRA), DIH Holding US (DHAI), and OSR (OSRH). Check-Cap vs. Its Competitors Direct Digital Sol-Gel Technologies Biotricity Nexalin Technology Tenon Medical Meihua International Medical Technologies Beyond Air Lyra Therapeutics DIH Holding US OSR Direct Digital (NASDAQ:DRCT) and Check-Cap (NASDAQ:CHEK) are related small-cap companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Does the media prefer DRCT or CHEK? In the previous week, Direct Digital had 2 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Direct Digital and 1 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.05 beat Direct Digital's score of -0.62 indicating that Check-Cap is being referred to more favorably in the news media. Company Overall Sentiment Direct Digital Negative Check-Cap Neutral Do insiders & institutionals believe in DRCT or CHEK? 4.0% of Direct Digital shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 62.8% of Direct Digital shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer DRCT or CHEK? Direct Digital currently has a consensus price target of $6.00, indicating a potential upside of 1,359.85%. Given Direct Digital's stronger consensus rating and higher possible upside, equities research analysts plainly believe Direct Digital is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Direct Digital 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DRCT or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -25.99%. Company Net Margins Return on Equity Return on Assets Direct Digital-25.99% N/A -36.29% Check-Cap N/A N/A N/A Which has more volatility and risk, DRCT or CHEK? Direct Digital has a beta of 6.04, meaning that its stock price is 504% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Which has higher earnings and valuation, DRCT or CHEK? Direct Digital has higher revenue and earnings than Check-Cap. Direct Digital is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDirect Digital$62.29M0.15-$6.24M-$1.83-0.22Check-CapN/AN/A-$17.57M-$3.00-0.21 SummaryDirect Digital beats Check-Cap on 10 of the 14 factors compared between the two stocks. Get Check-Cap News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHEK vs. The Competition Export to ExcelMetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.73M$6.82B$5.74B$9.56BDividend YieldN/A1.29%4.53%4.07%P/E Ratio-0.2126.3930.4325.14Price / SalesN/A66.68392.4187.63Price / CashN/A21.6837.0358.50Price / Book0.166.718.956.21Net Income-$17.57M$176.42M$3.26B$265.38M7 Day Performance-6.19%-2.78%1.03%-1.12%1 Month Performance-15.52%-2.53%4.28%-0.68%1 Year Performance-66.99%7.40%28.38%18.92% Check-Cap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEKCheck-Cap0.403 of 5 stars$0.64-1.2%N/A-66.3%$3.73MN/A-0.2180Short Interest ↑DRCTDirect Digital2.511 of 5 stars$0.40-3.2%$6.00+1,412.5%-87.9%$9.23M$62.29M-0.2260Short Interest ↑Gap DownSLGLSol-Gel Technologies1.0673 of 5 stars$16.10+4.3%N/A+309.8%$43.01M$23.93M-13.0950News CoveragePositive NewsEarnings ReportGap UpBTCYBiotricityN/A$0.60-4.8%N/A+3.1%$14.95M$12.06M-0.5640NXLNexalin Technology2.917 of 5 stars$0.80+2.6%$5.00+521.4%-26.9%$13.66M$170K-1.063Positive NewsTNONTenon Medical2.0768 of 5 stars$1.42+2.2%$5.50+287.3%+206.1%$12.34M$3.28M-0.058MHUAMeihua International Medical Technologies0.5085 of 5 stars$0.40+4.1%N/A-39.4%$12.23M$96.90M0.00620Short Interest ↑XAIRBeyond Air3.8465 of 5 stars$2.40+3.4%$11.00+358.3%-78.6%$12.12M$3.70M-0.2070News CoverageAnalyst ForecastShort Interest ↑Gap UpLYRALyra Therapeutics3.1774 of 5 stars$7.31+3.7%$100.00+1,268.0%-55.5%$11.59M$1.53M-0.2550Analyst RevisionGap DownDHAIDIH Holding US0.3689 of 5 stars$0.30+26.1%N/A-89.0%$11.33M$64.47M-1.01N/ANegative NewsShort Interest ↑Gap DownHigh Trading VolumeOSRHOSRN/A$0.56+5.8%N/AN/A$10.21MN/A0.00N/APositive NewsEarnings ReportGap Down Related Companies and Tools Related Companies DRCT Alternatives SLGL Alternatives BTCY Alternatives NXL Alternatives TNON Alternatives MHUA Alternatives XAIR Alternatives LYRA Alternatives DHAI Alternatives OSRH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHEK) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Check-Cap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access